Contact Person

Dr. Elinor Switzer

Managing Editor

Phone: +49 (0)711 - 2 29 87 63
Fax: +49 (0)711 - 2 29 87 65
send an Email


Revisiting the molecular epidemiology of factor XI deficiency: Nine new mutations and an original large 4qTer deletion in western Brittany (France)

Journal: Thrombosis and Haemostasis
ISSN: 0340-6245
Issue: 2012: 107/1 (Jan) pp. 1–199
Pages: 44-50

Revisiting the molecular epidemiology of factor XI deficiency: Nine new mutations and an original large 4qTer deletion in western Brittany (France)

P. Gueguen (1, 2, 3, 4), A. Chauvin (1, 2, 4), S. Quémener-Redon (1, 2, 5, 4), B. Pan-Petesch (3), C. Ferec (1, 2, 6, 5, 4), J.-F. Abgrall (1, 3, 4), C. Le Maréchal (1, 2, 6, 5, 4)

(1) Université de Brest, Faculté de Médecine et des Sciences de la Santé, UMR-S613, Brest, France; (2) Inserm, U613, Brest, France; (3) CHRU Brest, Service d’Hématologie biologique, Brest, France; (4) Université Européenne de Bretagne, Rennes, France; (5) CHRU Brest, Laboratoire de Génétique Moléculaire et d’Histocompatibilité, Brest, France; (6) Etablissement Français du Sang (EFS) Bretagne, France


deletion, mutation, factor XI deficiency, genetic analysis, F11 gene


Constitutional deficiency in factor XI (FXI) is a rare bleeding disorder in the general population, with the exception of Ashkenazi Jews. During the last decade, the detection of FXI-deficient patients has shifted from clinical screening identifying mostly severe bleeders to biological screening combining findings of prolonged activated partial thromboplastin time and FXI coagulation activity (FXI:C) below 50 U/dl. The goal of this study was to determine the molecular basis of FXI deficiency in western Brittany, France. Over the course of four years, we detected 98 FXI-deficient patients through biological screening, and 44 patients agreed to participate in this study corresponding to 25 index cases. We developed an efficient mutation detection strategy (combining direct sequencing and QFM-PCR to search for heterozygous rearrangements in a routine setting) that detected F11 mutations in 24 out of the 25 index cases. An unexpected allelic heterogeneity was found, with 14 different single point mutations being detected, among which nine are new. Moreover, a large heterozygous deletion of the entire F11 gene was detected, and was then further defined using a CGH array as a 4q34.2 telomeric deletion of 7 Mb containing 77 genes. We propose that the observed recurrent mutations may be considered as genetic tags of a population. This study highlights the importance of screening for large deletions in molecular studies of F11 .

You may also be interested in...

A. Wöhlke, C. Drögemüller, O. Distl

Tierärztliche Praxis Kleintiere 2007 35 5: 351-355

Akram Al-Hilali1, Karin Wulff2, Hikmat Abdel-Razeq3, Khalida Abu Saud1, Fateh Al-Gaili1, Falko H. Herrmann2

Thromb Haemost 2007 97 4: 542-545

A. Hafer, B. Mayer, H. Schunkert, J. Erdmann

Die Medizinische Welt 2007 58 1: 23-26